Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SYMBION FONDEN Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.2% 0.2%   Bankruptcy risk   1.0% 1.0% 0.9% 0.9% 0.9% 1.0% 12.2% 12.2%   Credit score (0-100)   89 87 89 88 88 85 20 20   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   1,411.5 1,235.3 1,604.9 1,595.5 1,455.9 1,313.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   396 399 402 403 413 456 456 456   Gross profit   364 367 370 370 380 423 0.0 0.0   EBITDA   364 367 370 370 380 423 0.0 0.0   EBIT   364 367 370 370 380 423 0.0 0.0   Pre-tax profit (PTP)   356.2 357.6 362.6 364.8 375.6 434.0 0.0 0.0   Net earnings   356.2 357.6 362.6 364.8 375.6 434.0 0.0 0.0   Pre-tax profit without non-rec. items   356 358 363 365 376 434 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   21,634 21,691 21,154 21,119 21,494 21,928 402 402   Interest-bearing liabilities   0.0 27.5 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   21,713 21,824 22,178 21,242 21,576 22,015 402 402   Net Debt   -1,351 -1,434 -1,340 -880 -1,214 -1,653 -402 -402     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   396 399 402 403 413 456 456 456   Net sales growth   1.6% 0.8% 0.7% 0.2% 2.6% 10.3% 0.0% 0.0%   Gross profit   364 367 370 370 380 423 0.0 0.0   Gross profit growth   2.4% 0.8% 0.7% 0.1% 2.6% 11.3% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   21,713 21,824 22,178 21,242 21,576 22,015 402 402   Balance sheet change%   -0.3% 0.5% 1.6% -4.2% 1.6% 2.0% -98.2% 0.0%   Added value   364.4 367.3 370.0 370.5 380.0 423.0 0.0 0.0   Added value %   91.9% 91.9% 92.0% 91.9% 91.9% 92.8% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   91.9% 91.9% 92.0% 91.9% 91.9% 92.8% 0.0% 0.0%   EBIT %   91.9% 91.9% 92.0% 91.9% 91.9% 92.8% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   89.9% 89.5% 90.2% 90.5% 90.9% 95.2% 0.0% 0.0%   Profit before depreciation and extraordinary items %   89.9% 89.5% 90.2% 90.5% 90.9% 95.2% 0.0% 0.0%   Pre tax profit less extraordinaries %   89.9% 89.5% 90.2% 90.5% 90.9% 95.2% 0.0% 0.0%   ROA %   1.7% 1.7% 1.7% 1.7% 1.8% 2.0% 0.0% 0.0%   ROI %   1.7% 1.7% 1.7% 1.8% 1.8% 2.0% 0.0% 0.0%   ROE %   1.6% 1.7% 1.7% 1.7% 1.8% 2.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   99.6% 99.4% 95.4% 99.4% 99.6% 99.6% 100.0% 100.0%   Relative indebtedness %   20.1% 33.1% 254.5% 30.7% 19.8% 19.1% 0.0% 0.0%   Relative net indebtedness %   -320.8% -332.7% -78.7% -187.7% -273.8% -343.3% -88.2% -88.2%   Net int. bear. debt to EBITDA, %   -370.8% -390.4% -362.2% -237.6% -319.5% -390.6% 0.0% 0.0%   Gearing %   0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 70.7% 53.9% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   17.0 11.0 1.8 7.1 14.8 19.0 0.0 0.0   Current Ratio   17.0 11.0 1.8 7.1 14.8 19.0 0.0 0.0   Cash and cash equivalent   1,351.1 1,461.5 1,340.2 880.1 1,214.0 1,652.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   340.9% 365.9% 451.4% 218.4% 293.6% 362.5% 88.2% 88.2%   Net working capital   1,271.5 1,329.1 791.7 756.5 1,132.1 1,566.1 0.0 0.0   Net working capital %   320.8% 332.7% 196.9% 187.7% 273.8% 343.4% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0